Sex Differences in Fetal Brain-Placental Immune Programming in Maternal Obesity

母亲肥胖中胎儿脑胎盘免疫编程的性别差异

基本信息

  • 批准号:
    10093233
  • 负责人:
  • 金额:
    $ 16.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY In the United States, one in three women of reproductive age is obese. In epidemiologic studies, maternal obesity is associated with neurodevelopmental morbidity in children, including cognitive deficits, autism spectrum disorder, anxiety and depression, disordered eating, and attention deficit hyperactivity disorder. Many of these disorders have a sex bias, and aberrant brain immune activation (microglial priming, or “trained immunity”), has been implicated in their pathogenesis. While direct evaluation of microglial function in a living human fetus or neonate is impossible, resident placental macrophages (Hofbauer cells) and microglia have a common origin in the fetal yolk sac. “Fetal Brain-Placental Immune Activation in Maternal Obesity” is a pre-clinical R01 that tests the hypothesis that maternal obesity-associated inflammatory priming of fetal brain microglia and placental Hofbauer cells is a targetable mechanism underlying offspring cognitive deficits. A key translational aspect of the funded project is the use of single-cell RNA sequencing (scRNA-Seq) to determine whether Hofbauer cells represent a novel biologic surrogate for microglial immunoreactivity in the setting of maternal obesity. In 2019, we were funded to complete the following specific aims: Aim 1a: Determine whether maternal obesity primes fetal brain and placental resident macrophages to overrespond to an immune challenge. Aim 1b: Evaluate whether Hofbauer cells can serve as a biologic surrogate for brain microglial priming, using scRNA-Seq and flow cytometry. Aim 2: Determine if targeted ablation of pro-inflammatory signaling in fetal resident tissue macrophages (including microglia and placental Hofbauer cells) rescues hippocampal learning deficits in offspring, using a novel Cx3cr1-CreBT:MyD88f/f transgenic mouse. Both sexes are evaluated in all experiments, except the scRNA-Seq in Aim 1b. We have completed initial sequencing for 16 male brain and placental macrophage samples from obese and lean dams. We have demonstrated novel gene programs and cell states that define male microglia and Hofbauer cells in the context of maternal obesity. This administrative supplement proposal aims to expand the scRNA-Seq experiments in Aim 1b of the parent grant to include female fetal microglia and placental macrophages. This will allow us to test whether maternal obesity induces sex-specific alterations in fetal microglial and Hofbauer cell programs, and whether Hofbauer cell subsets can serve as a biologic surrogate for fetal brain microglial priming in the setting of maternal obesity. Determination of how fetal sex impacts microglial and placental macrophage gene programs and cell states will generate key insights into how obesity-associated brain and placental immune activation influences sex-specific neurodevelopmental outcomes. If Hofbauer cells can serve as a more accessible cell type that provides information about brain microglial function in maternal obesity, there may be broader implications for assaying the impact of other maternal exposures on fetal brain immune activation. Understanding sex differences in fetal brain and placental immune programming in maternal obesity is critical to designing precision therapies.
项目总结 在美国,三分之一的育龄妇女患有肥胖症。在流行病学研究中,母亲肥胖 与儿童神经发育障碍有关,包括认知缺陷、自闭症谱系 精神障碍、焦虑和抑郁、饮食紊乱和注意力缺陷多动障碍。其中许多 疾病有性别偏见,而异常的大脑免疫激活(小胶质细胞启动,或“训练免疫”)有 与它们的发病机制有关。虽然直接评估活着的人胎儿或 新生儿是不可能的,常驻胎盘巨噬细胞(霍夫鲍尔细胞)和小胶质细胞有共同的起源 胎儿的卵黄囊。“母体肥胖的胎脑-胎盘免疫激活”是临床前R01测试 母体肥胖与胎儿脑小胶质细胞和胎盘炎症启动相关的假说 霍夫鲍尔细胞是导致后代认知缺陷的一种有针对性的机制。的一个关键翻译方面 资助的项目是使用单细胞RNA测序(scRNA-Seq)来确定霍夫鲍尔细胞 代表了母亲肥胖背景下小胶质细胞免疫反应的一种新的生物替代品。2019年, 我们获得资助是为了完成以下具体目标:目标1a:确定母亲肥胖是否为主要因素 胎脑和胎盘驻留巨噬细胞对免疫挑战反应过度。目标1b:评估 应用scRNA-Seq和Flow研究Hofbauer细胞能否作为脑小胶质细胞启动的生物替代物 细胞学。目的2:确定是否靶向消融胎儿常驻组织中的促炎信号 巨噬细胞(包括小胶质细胞和胎盘Hofbauer细胞)挽救大鼠海马区学习障碍 子代,使用新型CX3CR1-CreBT:MyD88f/f转基因小鼠。在所有的实验中都会对两性进行评估, 除Aim 1b中的scRNA-Seq外。我们已经完成了16个男性大脑和胎盘的初步测序 肥胖者和瘦肉者的巨噬细胞样本。我们已经展示了新的基因程序和细胞状态 这在母体肥胖的背景下定义了男性小胶质细胞和霍夫鲍尔细胞。 这项行政补充提案旨在扩大父母目标1b中的scRNA-Seq实验 批准包括女性胎儿小胶质细胞和胎盘巨噬细胞。这将使我们能够测试母体 肥胖导致胎儿小胶质细胞和霍夫鲍尔细胞程序的性别特异性改变,以及霍夫鲍尔是否 在母体肥胖的情况下,细胞亚群可以作为胎儿脑小胶质细胞启动的生物替代物。 确定胎儿性别对小胶质细胞和胎盘巨噬细胞基因程序和细胞状态的影响 对肥胖相关的大脑和胎盘免疫激活如何影响特定性别提供关键见解 神经发育结果。如果Hofbauer细胞可以作为一种更容易获得的细胞类型,提供 关于母亲肥胖的大脑小胶质细胞功能的信息,可能对检测有更广泛的意义 其他母亲接触对胎儿大脑免疫激活的影响。了解胎儿的性别差异 母体肥胖的大脑和胎盘免疫程序对于设计精确的治疗方法至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea Goldberg Edlow其他文献

Andrea Goldberg Edlow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea Goldberg Edlow', 18)}}的其他基金

Research Project 1 - The pregnancy ImmunOME
研究项目 1 - 妊娠 ImmunOME
  • 批准号:
    10611526
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection
母体 SARS-CoV-2 感染时胎儿神经发育的细胞模型
  • 批准号:
    10612535
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
MOMI Clinical Core
MOMI 临床核心
  • 批准号:
    10420108
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
MOMI Clinical Core
MOMI 临床核心
  • 批准号:
    10611522
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Research Project 1 - The pregnancy ImmunOME
研究项目 1 - 妊娠 ImmunOME
  • 批准号:
    10420109
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Maternal obesity and inflammation as drivers of maternal morbidity in COVID-19
孕产妇肥胖和炎症是 COVID-19 孕产妇发病的驱动因素
  • 批准号:
    10200505
  • 财政年份:
    2019
  • 资助金额:
    $ 16.84万
  • 项目类别:
Helping Us Grow Stronger (HUGS/Abrazos): COVID-19 in pregnancy and reducing toxic stress in mother-infant dyads
帮助我们变得更强 (HUGS/Abrazos):怀孕期间的 COVID-19 和减少母婴二人的毒性压力
  • 批准号:
    10393329
  • 财政年份:
    2019
  • 资助金额:
    $ 16.84万
  • 项目类别:
Fetal Brain-Placental Immune Activation in Maternal Obesity
母亲肥胖中胎儿脑胎盘免疫激活
  • 批准号:
    10229462
  • 财政年份:
    2019
  • 资助金额:
    $ 16.84万
  • 项目类别:
Fetal Brain-Placental Immune Activation in Maternal Obesity
母亲肥胖中胎儿脑胎盘免疫激活
  • 批准号:
    10002284
  • 财政年份:
    2019
  • 资助金额:
    $ 16.84万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 16.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了